Effect of dapagliflozin on uric acid in patients with chronic heart failure and hyperuricemia
{{output}}
Background: Patients with chronic heart failure (CHF) frequently develop hyperuricemia, an elevated serum uric acid level, associated with adverse outcomes. Dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, demonstrates ... ...
